Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 15 | 13 | +1,68 % | ||
| BIOGEN | 5 | 54 | -5,39 % | ||
| MODERNA | 5 | 16 | +3,38 % | ||
| TRAVERE THERAPEUTICS | 5 | 11 | -4,00 % | ||
| SOLID BIOSCIENCES | 4 | - | +12,98 % | ||
| EXELIXIS | 3 | 8 | +1,37 % | ||
| IMMUNITYBIO | 3 | 3 | +7,12 % | ||
| AMGEN | 2 | 27 | +0,77 % | ||
| C4 THERAPEUTICS | 2 | 5 | +0,86 % | ||
| AQUESTIVE THERAPEUTICS | 2 | 2 | +3,37 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:26 | JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns | 4 | FierceBiotech | ||
| 20:42 | Grail and Indivior PLC come out on top in Healthcare quant picks ahead of Q4 earnings | 1 | Seeking Alpha | ||
| 20:30 | EILMELDUNG: Biontech startet durch - beginnt jetzt die Rallye? - nicht verpassen! | Hebelschein-Spekulant | |||
| 20:10 | Aktien New York: Verluste - Tech-Schwergewichte und Banken unter Druck | 411 | dpa-AFX | NEW YORK (dpa-AFX) - Die US-Aktienmärkte haben zur Wochenmitte an ihre Abwärtstendenz vom Vortag angeknüpft. Dabei führten schwergewichtete Technologiewerte die Liste der Verlierer an. Ebenfalls in... ► Artikel lesen | |
| 19:46 | JPM26: Regeneron will not overpay in M&A deals amid lead asset patent expiries | 7 | Pharmaceutical Technology | ||
| 18:46 | JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition | 2 | Pharmaceutical Technology | ||
| 18:43 | Commonwealth Fusion Systems Adds Moderna CEO Stephane Bancel To Board | 7 | pulse2.com | ||
| 18:42 | Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses | 7 | Benzinga.com | ||
| 18:36 | Sanofi: Information concerning the total number of voting rights and shares - December 2025 | 6 | GlobeNewswire (USA) | ||
| 18:10 | Amneal and VantAI unveil fresh branding to kick off 2026 plans | 1 | FiercePharma | ||
| 18:10 | FDA delays decision on Travere's Filspari in key kidney disease indication | 2 | FiercePharma | ||
| 18:00 | Solid Bio rises as Duchenne study gets fully enrolled | 3 | Seeking Alpha | ||
| 17:45 | Sana Biotechnology, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17:42 | AstraZeneca Acquires Modella AI To Scale Multimodal AI And Agents Across Oncology R&D | 8 | pulse2.com | ||
| 17:38 | NOVAVAX INC unter Beobachtung - Fokus auf Substanz | 5 | Maximilian Berger | ||
| 16:54 | Moderna - Boden komplett | Société Générale | |||
| 16:34 | Apogee Therapeutics auf Rekordhoch: Aktie erreicht 81,0 USD | 3 | Investing.com Deutsch | ||
| 16:10 | TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA | 3 | Zacks | ||
| 16:07 | Truist Securities raises Exelixis stock price target to $51 on oncology growth | 1 | Investing.com | ||
| 16:02 | Levi & Korsinsky, LLP: Lost Money on CorMedix Inc. (CRMD)? Contact Levi & Korsinsky About Fraud Investigation | 206 | Newsfile | New York, New York--(Newsfile Corp. - January 14, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into CorMedix Inc. ("CorMedix Inc.") (NASDAQ: CRMD) concerning... ► Artikel lesen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .